Title
Category
Credits
Event date
Cost
- Dementia
- CME Activities
- Neurology
- 1.00 AMA PRA Category 1 Credit™
06/24/2025
$0.00
This webinar will provide an in-depth review of cerebral amyloid angiopathy and vascular dementia, including their epidemiology, pathology, diagnosis, and management. It will also explore the vascular risks and complications associated with emerging Alzheimer’s monoclonal antibody therapies—aducanumab, lecanemab, and donanemab with a focus on amyloid-related imaging abnormalities (ARIA) and their implications for clinical practice.